The gut microbiome has a tremendous influence on human physiology, including the
nervous system. During fetal development, the initial colonization of the microbiome …

Background Patients with schizophrenia display peripheral inflammation but the impact of
illness phase is not clear. Our meta-analysis investigated the difference in CRP levels …

The longstanding investigation of immune system abnormalities, including inflammation, in
schizophrenia has tremendous renewed interest as an area of research. Presently, the field …

Background The brain-gut axis has gained increasing attention due to its contribution to the
etiology of various central nervous system disorders. This study aims to elucidate the …

Objective Schizophrenia is associated with abnormal levels of blood inflammatory markers,
which may be correlated with levels of psychopathology. Few previous studies have …

Background Cardiovascular disease (CVD) risk factors such as dyslipidemia and systemic
aberrant inflammatory processes may occur in patients with psychotic disorders, which may …

The present study aims at comparing the change in cytokine levels in schizophrenia patients
treated with atypical antipsychotics, with or without metabolic syndrome (MetS). The study …

Abstract Increased blood interleukin-6 (IL-6) levels are a replicated abnormality in
schizophrenia, and may be associated with smaller hippocampal volumes and greater …

Abstract Introduction Metabolic syndrome (MetS) is a cluster of components including
abdominal obesity, hyperglycemia, hypertension, and dyslipidemia. MetS is highly prevalent …

Background: Total white blood cell count (TWBCc), an index of chronic and low-grade
inflammation, is associated with clinical symptoms and metabolic alterations in patients with …